Cullinan Oncology, Inc. (CGEM) Tops Q1 EPS by 8c

May 7, 2026 7:10 AM EDT

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q1 EPS of ($0.75), $0.08 better than the analyst estimate of ($0.83).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK